By Josh Beckerman
Avinger shares fell after the company said it would seek shareholder approval for a potential assignment for the benefit of creditors followed by a voluntary dissolution and liquidation.
The medical-device company's stock was down 27%, to 60 cents, in after hours Wednesday after closing flat, at 82 cents.
Avinger said in a proxy filing that it expects to continue to generate operating losses and consume significant cash resources for the foreseeable future. It doesn't expect its cash and cash equivalents to be sufficient to continue as a going concern for any significant period of time.
"Although we are currently exploring various strategic alternatives, including strategic partners and financing opportunities, it is unlikely that these strategic alternatives will be successful in the next few weeks prior to our cash position getting to the point that we will need to pursue our winding down and dissolution," the company said.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
December 11, 2024 18:58 ET (23:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。